Axoft

About

Axoft is a neurotechnology company based in Cambridge, Massachusetts, founded in 2021. The company focuses on developing bioinspired neural implants that interface with the nervous system to treat long-term neurological disorders. Axoft has raised a total of $18.58 million in funding, including an $8 million seed round led by The Engine, and has received FDA Breakthrough Device designation for its innovative implant technology. The company's core offerings include ultra-flexible, biocompatible neural implants that mimic brain tissue properties, significantly reducing scarring and enhancing long-term stability. Axoft also develops integrated signal processing electronics for wireless neural data transmission, precision surgical tools for minimally invasive implantation, and proprietary software for decoding high-bandwidth neural signals. With a mission to improve clinical outcomes for neurological disorders, Axoft aims to address severe medical needs through its advanced brain-machine interfaces.